Literature DB >> 30711537

CircRNAs and lung cancer: Biomarkers and master regulators.

Xin Di1, Xin Jin2, Ranwei Li3, Min Zhao1, Ke Wang4.   

Abstract

CircRNAs are a class of competitive, endogenous, non-coding RNAs with closed-loop structures. High-throughput sequencing indicates that circRNAs are ubiquitously expressed in many eukaryotes. Biological functions of circRNAs include interaction with proteins and regulation of gene transcription, translation, and miRNA sponge activity. These functions suggest that circRNAs may be useful as novel biomarkers for disease diagnosis and prognosis. Lung cancer is known worldwide as the most common malignant tumor. It is also the main cause of cancer-related death. In recent years, it has become increasingly evident that circRNAs are involved in the proliferation, migration, and invasion of lung cancer cells. Differentially expressed circRNAs may be used as non-invasive diagnostic and prognostic markers for lung cancer. Therefore, they are considered a research hotspot for lung cancer studies. This article is a systematic review of mechanisms underlying the action, diagnosis, clinical aspects, and drug resistance of circRNAs in lung cancer.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Biomarker; Circular RNA; Lung cancer; MicroRNA sponge; Treatment

Mesh:

Substances:

Year:  2019        PMID: 30711537     DOI: 10.1016/j.lfs.2019.01.055

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  29 in total

1.  Circ_0000376 downregulation inhibits the progression of non-small cell lung cancer by mediating the miR-488-3p/BRD4 axis and the PI3K/PKB signaling pathway.

Authors:  Hongmei Yuan; Hongge Wu; Jing Cheng; Jie Xiong
Journal:  Histol Histopathol       Date:  2021-11-03       Impact factor: 2.303

2.  Construction and validation of a novel prediction system for detection of overall survival in lung cancer patients.

Authors:  Cheng Zhong; Yun Liang; Qun Wang; Hao-Wei Tan; Yan Liang
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

3.  Depleting hsa_circ_0000567 suppresses acquired gefitinib resistance and proliferation of lung adenocarcinoma cells through regulating the miR-377-3p / ZFX axis: an in vitro and in vivo study.

Authors:  Lanjun Wang; Mengqi Li; Rong Lian
Journal:  Histol Histopathol       Date:  2022-02-08       Impact factor: 2.130

4.  Relationship between heat treatment on structural properties and antitumor activity of the cold-water soluble polysaccharides from Grifola frondosa.

Authors:  Xiao-Qing Li; An-Jun Liu
Journal:  Glycoconj J       Date:  2019-12-10       Impact factor: 2.916

Review 5.  Epithelial-mesenchymal transition-related circular RNAs in lung carcinoma.

Authors:  Meina Jiang; Shuai Fang; Xiaodong Zhao; Chengwei Zhou; Zhaohui Gong
Journal:  Cancer Biol Med       Date:  2021-03-12       Impact factor: 4.248

6.  Circular RNA circSLC8A1 inhibits the proliferation and invasion of non-small cell lung cancer cells through targeting the miR-106b-5p /FOXJ3 axis.

Authors:  Wenmu Yong; Shujiao Deng; Yunfang Tan; Sen Li
Journal:  Cell Cycle       Date:  2021-11-01       Impact factor: 4.534

7.  Circular RNA circFAT1(e2) Promotes Colorectal Cancer Tumorigenesis via the miR-30e-5p/ITGA6 Axis.

Authors:  Fei Pan; Dongqing Zhang; Na Li; Mei Liu
Journal:  Comput Math Methods Med       Date:  2021-06-26       Impact factor: 2.238

8.  Blocking circ_0014130 suppressed drug resistance and malignant behaviors of docetaxel resistance-acquired NSCLC cells via regulating miR-545-3p-YAP1 axis.

Authors:  Dongjie Du; Xiaoci Cao; Xinbo Duan; Xianbo Zhang
Journal:  Cytotechnology       Date:  2021-05-25       Impact factor: 2.040

Review 9.  The Biogenesis and Functions of piRNAs in Human Diseases.

Authors:  Xi Wu; Yutian Pan; Yuan Fang; Jingxin Zhang; Mengyan Xie; Fengming Yang; Tao Yu; Pei Ma; Wei Li; Yongqian Shu
Journal:  Mol Ther Nucleic Acids       Date:  2020-05-23       Impact factor: 8.886

10.  Circ_0044516 Regulates miR-136/MAT2A Pathway to Facilitate Lung Cancer Development.

Authors:  Yue-Wei Chen; Qiu-Rong Du; Yu-Juan He; Wen-Shu Chen; Wen-Yang Jiang; Qi Gui; Cheng-Cheng Xu; Wei Wang; Hong-Yun Cheng
Journal:  J Immunol Res       Date:  2021-06-24       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.